ROYAL BANK OF CANADA - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$119,000
+296.7%
19,676
+137.1%
0.00%
Q3 2019$30,000
+50.0%
8,300
+10.7%
0.00%
Q2 2019$20,000
-45.9%
7,500
-40.0%
0.00%
Q1 2019$37,000
+825.0%
12,509
+400.4%
0.00%
Q4 2018$4,000
-81.8%
2,500
-59.1%
0.00%
Q3 2018$22,000
+1000.0%
6,115
+778.6%
0.00%
Q2 2018$2,000
-33.3%
696
-22.1%
0.00%
Q4 2017$3,000
-94.3%
894
-92.4%
0.00%
Q3 2017$53,000
+1225.0%
11,756
+1311.3%
0.00%
Q2 2017$4,000
-81.8%
833
-84.0%
0.00%
Q1 2017$22,000
-88.4%
5,209
-88.6%
0.00%
Q4 2016$189,000
-39.4%
45,776
+18.9%
0.00%
Q3 2016$312,000
-22.0%
38,514
-25.0%
0.00%
Q2 2016$400,000
-19.5%
51,381
-20.2%
0.00%
Q1 2016$497,000
-12.5%
64,385
+22.2%
0.00%
Q4 2015$568,000
+1134.8%
52,668
+697.4%
0.00%
Q3 2015$46,000
+411.1%
6,605
+529.0%
0.00%
Q2 2015$9,000
-76.3%
1,050
-73.2%
0.00%
Q1 2015$38,000
-80.2%
3,915
-74.9%
0.00%
Q4 2014$192,000
-38.3%
15,600
-50.0%
0.00%
Q3 2014$311,000
+1973.3%
31,200
+1460.0%
0.00%
Q2 2014$15,000
-80.5%
2,000
-91.5%
0.00%
Q1 2014$77,000
-18.9%
23,607
-17.5%
0.00%
Q4 2013$95,000
-22.1%
28,607
-29.2%
0.00%
Q3 2013$122,000
+117.9%
40,420
+494.4%
0.00%
Q2 2013$56,0006,8000.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
RA Capital Management 12,033,220$92,896,00011.87%
RTW INVESTMENTS, LP 2,558,859$19,754,0007.17%
TURNER INVESTMENTS LLC 859,560$6,636,0001.80%
DAFNA Capital Management LLC 236,500$1,826,0001.58%
Ghost Tree Capital, LLC 250,000$1,930,0001.09%
Orbimed Advisors 11,519,700$88,932,0000.94%
Rock Springs Capital Management LP 1,220,000$9,418,0000.79%
Opus Point Partners Management, LLC 99,000$764,0000.59%
Bellevue Group AG 420,000$3,242,0000.59%
Cormorant Asset Management, LP 500,000$3,860,0000.58%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders